ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 63 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $477,000 | -22.4% | 150,000 | 0.0% | 0.31% | -21.7% |
| Q4 2017 | $615,000 | -80.6% | 150,000 | -78.6% | 0.40% | -54.0% |
| Q3 2017 | $3,164,000 | +137.5% | 700,000 | +75.0% | 0.87% | +15.8% |
| Q2 2017 | $1,332,000 | -70.5% | 400,000 | -18.4% | 0.75% | -66.3% |
| Q1 2017 | $4,513,000 | +6.4% | 490,000 | -10.9% | 2.23% | -12.0% |
| Q4 2016 | $4,241,000 | -74.4% | 550,000 | -62.1% | 2.54% | -14.2% |
| Q3 2016 | $16,574,000 | +113.0% | 1,450,000 | +129.4% | 2.96% | -6.7% |
| Q2 2016 | $7,782,000 | +64.8% | 632,200 | +35.4% | 3.17% | +83.0% |
| Q1 2016 | $4,722,000 | -47.6% | 467,025 | +16.8% | 1.73% | -41.7% |
| Q4 2015 | $9,016,000 | +334.7% | 400,000 | +220.0% | 2.97% | +263.6% |
| Q3 2015 | $2,074,000 | -7.8% | 125,000 | +25.0% | 0.82% | +14.9% |
| Q2 2015 | $2,250,000 | – | 100,000 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|